Accurate diagnosis is vital for the successful management of patients with HCM. Mistakes and delays in diagnosis are common. Hypertrophic cardiomyopathy commonly “masquerades” as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with HCM can be effectively managed to improve both symptoms and survival. Today, the diagnosis of HCM relies on the identification of increased left ventricular wall thickness on imaging. Diagnosis is most often made using echocardiographic assessment of LVH, LVOT gradients, systolic and diastolic function, and mitral valve anatomy and function. Cardiac magnetic resonance imaging also has a diagnostic role by determining the extent and location of LVH and the anatomic abnormalities of the mitral valve and papillary muscles. In this program internationally expert faculty will review the importance of accurate and comprehensive imaging in the diagnosis and management of HCM, offering tips and tricks for both performing echocardiography and interpreting echo and CMR scans.
Cardiologists, interventional cardiologists, electrophysiologists, cardiac surgeons and other healthcare professionals involved in the treatment and management of patients with hypertrophic cardiomyopathy (HCM)
Improve understanding of the prevalence, pathophysiology, unmet patient needs, and natural course of HCM
Develop a clear understanding of the implications of undiagnosed, untreated, and undertreated HCM and its associated comorbidities
Increase confidence and competence in diagnostic skill for recognizing HCM, including echocardiographic evaluation
Increase familiarity with, and clinical confidence to apply, current, evidence-based guidelines on managing HCM
Develop a greater awareness of novel and emerging pathophysiology-based mechanisms of action for pharmaceuticals that treat HCM, the clinical data that supports these MOAs, and the impact of these data on guidelines and practice
Echocardiography for HCM Imaging
Cardiac MRI for HCM Imaging
Echocardiography Tips and Techniques for Optimizing Imaging in Patients with or at Risk for HCM
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships relating to the topics of this educational activity. Any relevant financial relationships are mitigated via a content review by planning committee members and faculty with no relevant financial relationships.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
| Faculty | Relationship Identified With: |
| Theodore Abraham, MD
|
Grant/Research Support: Bristol-Myers Squibb; Cytokinetics; Echonous Ultrasound; Tenaya Therapeutics; Imbria; GE HealthCare; Philips Ultrasound |
| Prof. Thor Edvardsen
|
Nothing to disclose. |
| Isaac Kwan | Nothing to disclose. |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Benedek hereby state that they or their spouse/life partner do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit TM.
Clinicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from Bristol Myers Squibb.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Bristol Myers Squibb do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
In order to claim credit, participants must complete the following:
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606